Hims & Hers (NYSE: HIMS) has seen incredibly high growth, but the market is skeptical that will continue. In this video, Travis Hoium shows just how cheap the stock is today. *Stock prices used ...

Universal's Wicked clocked 882 million minutes viewed in Nielsen's preliminary streaming chart for the period of March 17-23.

What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain first-hand. Shares of the health and wellness platform operator ...

Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering compounded versions of Ozempic and Wegovy. This approach is in response to ...

Introduction: What Even Is Hims & Hers Health? In the pop culture of the investing community, Hims & Hers Health, Inc. (NYSE:HIMS) (Hims for short) has been described in all manner of ways ...

Hims & Hers is a newfangled telehealth company that started to ride the waves of GLP-1 weight loss medications. As waves go, this one’s given the stock a heck of ride; way up and then all the ...

In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other Wednesday’s top performers. The stock market regained momentum on Wednesday ...

Deep-pocketed investors have adopted a bearish approach towards Hims & Hers Health HIMS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry. Hims ...

Bank of America raised its price target on Hims & Hers Health, but still thinks you should sell the stock. February saw a spike in weight loss sales at the drug compounder, but future sales of ...